Novant Health Medical Group, LLC
Novant Health Medical Group, LLC was paid $15.37M by Medicaid between Jun 2023 and Dec 2024, across 82 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 59% of everything it billed.
CHARLOTTE, NC 28262
Next to other Internal Medicine Physician providers in North Carolina
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2023 | 94,719 | $4.40M | |
| 2024incomplete | 238,426 | $10.97M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 59% | 126,464 | 114,861 | $9.03M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 21% | 60,616 | 55,615 | $3.29M |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3.2% | 8,070 | 7,713 | $487K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.9% | 9,518 | 8,962 | $444K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.2% | 8,290 | 7,612 | $340K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.8% | 9,910 | 9,385 | $282K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.5% | 2,472 | 2,132 | $233K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.5% | 2,336 | 2,168 | $231K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 1,555 | 1,428 | $151K |
| 96127 | <1% | 32,801 | 31,384 | $150K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 1,840 | 1,699 | $148K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 876 | 821 | $94K |
70 more codes
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 750 | $80K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,299 | $56K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 5,728 | $55K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 1,868 | $31K |
| 90837 | Psychotherapy session, about an hour | <1% | 351 | $29K |
| 99199 | Unlisted special service, procedure or report | <1% | 9,181 | $27K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,714 | $25K |
| 99051 | <1% | 1,030 | $24K | |
| 87634 | <1% | 683 | $19K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,489 | $15K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,893 | $13K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 4,141 | $12K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 140 | $11K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 792 | $10K |
| 90461 | <1% | 2,371 | $10K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 105 | $9K |
| 90674 | <1% | 1,975 | $8K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 590 | $8K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 555 | $8K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 583 | $8K |
| 81003 | <1% | 2,980 | $6K | |
| 87807 | <1% | 341 | $5K | |
| 90661 | <1% | 1,016 | $4K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 221 | $3K |
| 96161 | <1% | 613 | $2K | |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 51 | $2K |
| 90677 | <1% | 823 | $2K | |
| 99385 | <1% | 13 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 83 | $1K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 41 | $1K |
| 80305 | <1% | 113 | $1K | |
| D1206 | Topical application of fluoride varnish | <1% | 52 | $853.80 |
| 81001 | <1% | 264 | $849.29 | |
| G0136 | Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months | <1% | 1,979 | $818.31 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 12 | $536.68 |
| 81025 | <1% | 58 | $440.29 | |
| 93000 | <1% | 14 | $135.90 | |
| 92551 | <1% | 1,626 | $114.63 | |
| 99173 | <1% | 1,898 | $108.64 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 28 | $84.71 |
| 92552 | <1% | 652 | $82.73 | |
| 85027 | <1% | 13 | $78.14 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 35 | $55.13 |
| 82948 | <1% | 14 | $39.62 | |
| 82043 | <1% | 14 | $34.62 | |
| 82570 | <1% | 14 | $30.96 | |
| 90656 | <1% | 106 | $22.11 | |
| 90686 | <1% | 178 | $19.55 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 13 | $2.53 |
| 99000 | 0% | 1,791 | $0.00 | |
| 90651 | 0% | 34 | $0.00 | |
| 90680 | 0% | 342 | $0.00 | |
| 90698 | 0% | 85 | $0.00 | |
| 90723 | 0% | 407 | $0.00 | |
| J3535 | Drug administered through a metered dose inhaler | 0% | 19 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 82 | $0.00 |
| 99174 | 0% | 66 | $0.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 67 | $0.00 |
| 90696 | 0% | 18 | $0.00 | |
| 90744 | 0% | 13 | $0.00 | |
| 90700 | 0% | 42 | $0.00 | |
| 99177 | 0% | 1,296 | $0.00 | |
| 90734 | 0% | 77 | $0.00 | |
| 90648 | 0% | 882 | $0.00 | |
| 90633 | 0% | 240 | $0.00 | |
| 90653 | 0% | 29 | $0.00 | |
| 90670 | 0% | 298 | $0.00 | |
| 90710 | 0% | 50 | $0.00 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 15 | $0.00 |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | 0% | 41 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.